






Reazioni avverse al cibo.
Riassunto
Negli ultimi decenni sono aumentate considerevolmente le reazioni avverse al cibo nei cani 
e nei gatti. In questo studio si riportano i sintomi da intolleranza alimentare, tra cui otite, 
diarrea, ansia generalizzata e dermatite, in 8 cani che consumavano regolarmente diete 
commerciali a base di crocchette. Tutti i cani hanno ricevuto dieta commerciale a base di 
pollo biologico per 15 giorni misurando, all'inizio e alla fine della valutazione, i parametri 
emato‑biochimici, la composizione delle crocchette che avevano assunto precedentemente 
e la concentrazione sierica di ossitetraciclina (OTC). Si è ipotizzato che l'assunzione cronica 
di cibo contaminato, accresciuta dalla presenza di aggregati di nanoparticelle, potrebbe 
essere alla base dell'insorgenza d'intolleranze alimentari farmacologiche o idiopatiche. Al 
termine del periodo di valutazione la sintomatologia clinica è regredita significativamente. 
Le analisi biochimiche hanno evidenziato un aumento significativo della fosfatasi alcalina 
dopo 15  giorni da 41 a 52,5  U/L (**p < 0.01), mentre è stata osservata una diminuzione 
significativa della gamma‑glutamil transferasi e dell'urea, rispettivamente da 9,37 a 
6,25 U/L e da 32,13 ± 8,72 a 22,13 ± 7,8 mg/dL (*p < 0.05). L'analisi della composizione delle 
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In the last decades, adverse food reactions have increased considerably in dogs and cats. In 
this study we report on the possible onset of food intolerances symptoms, including otitis, 
diarrhoea, generalised anxiety, and dermatitis in a cohort of 8 dogs consuming commercial 
diets. All dogs received an organic chicken‑based diet for 15 days. We performed analysis 
of blood biochemical parameters, kibble composition, and oxytetracycline (OTC) serum 
concentration before and after 15 days of organic chicken‑based diet supplementation. 
We hypothesised that a chronic intake of contaminated food enhanced by the presence of 
nanoparticle aggregates might be at the base of the onset of pharmacologic or idiopathic 
food intolerances. At the end of the evaluation period, an overall significant reduction of 
otitis, diarrhoea, generalised anxiety, and dermatitis was observed. Biochemical analyses 
indicate a significant increase in the alkaline phosphatase, from 41 to 52.5 U/L, after 15 days 
(**p < 0.01), while a significant decrease in Gamma‑glutamyl transferase and urea, from 
9.37 to 6.25 U/L and from 32.13  ±  8.72 to 22.13  ±  7.8 mg/dL, respectively, was observed 
(*p < 0.05). A significant decrease, from 0.22 to 0.02 μg/mL, in mean OTC serum concentration 
was also observed (**p < 0.01). Composition analysis revealed the presence of OTC, calcium, 
aluminium, silicon, and phosphorous nanoparticle aggregates. Further research on a wider 
sample size would help to confirm the hypothesis proposed here.
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OTC bound to chicken bone, which is widely used 
in pet food production (Odore et al. 2015, Di Cerbo 
et  al. 2016b). However in that study we didn’t 
provide direct evidence of the clinical impact of 
OTC‑contaminated pet food on the animal’s health. 
In this study we also report the usefulness of an 
organic chicken‑based diet supplementation in 
relieving AFR‑related symptoms in a small cohort of 
dogs within 15 days.   
Materials and methods 
In this study we enrolled 8 client‑owned 
indoor‑housed neutered dogs with otitis, diarrhea, 
generalized anxiety, and dermatitis that were 
aroused after food ingestion. The dogs were of 
different breeds, sex (2 males and 6 females) and 
age (mean age ± standard error of mean; 3.62 ± 0.74 
years) with otitis, diarrhoea, generalised anxiety, and 
dermatitis. We also performed complete profiles of 
blood biochemical parameters and kibbles (which 
belonged to their diets) composition. 
Blood biochemical parameter 
evaluation
We analysed blood biochemical parameters (calcium, 
cholesterol, triglycerides, creatine phosphokinase, 
total bilirubin, albumin, alkaline phosphatase, 
creatinine, gamma‑glutamyl transferase, 
glucose, glutamic‑oxaloacetic transaminase, 
glutamic‑pyruvic transaminase, phosphorous, 
total protein, and urea) using a chemistry analyser 
(Dimension RXL, Siemens S.p.A, Milan, Italy). Serum 
protein electrophoresis was examined with GENIO S 
device (Interlab s.r.l., Rome, Italy).
Enzyme‑linked immunosorbent assay 
(ELISA) for serum OTC evaluation
Based on previous observations (Di Cerbo et  al. 
2014a, Mazzeranghi et  al. 2017), 4 mL of blood 
was withdrawn from each dog at first visit and 
after 15 days of their new diet supplementation. 
Blood samples were analysed using an OTC‑specific 
ELISA kit for pets (Cat. # DE – 100430, Genemed 
Synthesis, Inc., San Antonio, USA). Two healthy dogs 
were chosen as the control group. Their serum OTC 
concentration was far below the detection threshold.
Introduction
Adverse food reactions (AFR) are clinical responses 
following the ingestion of a dietary component 
(Cianferoni and Spergel, 2009). They can cause 
cutaneous and/or gastrointestinal signs in dogs and 
cats (Gaschen and Merchant 2011). 
These reactions can be divided into toxic 
(food poisoning) and non‑toxic, which 
are further subdivided into non‑immune 
mediated (food intolerances) and immune 
mediated [Immunoglobulin E (IgE)‑mediated, 
non‑IgE‑mediated food allergies, and celiac disease] 
(Ortolani and Pastorello 2006).
While toxic food reactions can occur because of the 
presence of a toxin in a particular foodstuff, or are 
a consequence of food processing, IgE‑mediated 
food allergies represent most common adverse food 
reactions (Ortolani and Pastorello 2006). Conversely, 
non‑IgE‑mediated food allergies are immune 
reactions, which depend on antibodies (different from 
IgE), food and food antibodies immune complexes 
and even cell‑mediated immunity. Food intolerances 
can result from enzymatic defects (β‑galactosidase 
deficiency) (Mattar et al. 2012), or can arise after the 
intake of vasoactive amines (dopamine, histamine, 
norepinephrine, phenylethylamine, serotonin, and 
tyramine) that are present in foods (Metcalfe et  al. 
2011). Vasoactive amine histamine, degraded by 
microorganisms from histidine, is frequently present 
in high quantities in cheese, alcoholic beverages, 
and fermented foods (e.g. spoiled fish) (Ortolani 
and Pastorello 2006). Symptoms of histaminic 
intoxication are erythema, vasodilation, tachycardia, 
hypertension, migraine, vomiting, and diarrhoea, 
which generally resolve within a few hours (Maire 
et  al. 1992). Other non‑classifiable reactions are 
regarded as undefined (idiopathic) food intolerances 
and, in predisposed individuals, can be due to the 
presence of food additives (sulphites, nitrites, nitrates, 
monosodium glutamate, and some colourings and 
even antibiotics) (Ortolani and Pastorello 2006, Di 
Cerbo et al. 2014a). 
The aim of this preliminary study is to provide new 
insights into idiopathic food intolerances in dogs 
with a particular focus on the role of antibiotics (e.g. 
oxytetracycline, OTC) or their metabolites as possible 
triggering factors. We previously demonstrated 
the pro‑apoptotic and pro‑inflammatory role of 
crocchette ha rivelato la presenza di OTC, calcio, alluminio, silicio, fosforo e aggregati di 
nanoparticelle. Ulteriori ricerche su un campione più ampio contribuirebbero a confermare 
l'ipotesi qui proposta.
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Determination of cell viability
Serial dilutions of powder OTC (150, 75, 35, and 
15  μg/ml) or liquid OTC (350, 175, 87.5, and 40 
μg/ml) were prepared in RPMI culture medium. 
Cell viability was assessed after 24‑48‑72 
hours of continuous exposure with the above 
concentrations. A Cell Counting Kit‑8 (CCK‑8) assay 
(Dojindo Laboratories, Kumamoto, Japan) was 
used to measure the cytotoxicity on K562 cell line. 
Briefly, the K562 cells were plated on 96‑well plates 
(Euroclone, Milan, Italy) at concentrations of 5,000 
or 10,000 cells/cm2. After being exposed to the 
desired concentrations of the different compounds, 
10  µl of CCK‑solution was added to each well and 
incubated for a period of 2 hours at 37  °C. Finally, 
absorption was measured at 450  nm using a 
multiplate reader Multiscan FC (Thermo Scientific, 
USA). Dimethyl sulfoxide (DMSO) 3% was used as a 
toxic reference drug. Cell viability was expressed as 
a percentage of that of the untreated cells (control). 
For each concentration of tested compounds, mean 
values of the mean absorbance rates from four wells 
were calculated.
Nanoparticle detection
Nine samples of kibbles belonging to different 
brands were collected and analysed for the presence 
of inorganic foreign bodies. We hypothesised that 
daily intake of kibbles contaminated with antibiotic 
residues contributed to the onset of otitis, diarrhoea, 
generalised anxiety, and dermatitis in dogs. From 
each kibble a 1‑2 cm2 sample was detached, put on 
a carbon adhesive disk and then transferred to an 
aluminium stub to rule out the possible presence 
of any environmental pollutants. Samples were 
analysed in triplicate to check the repeatability 
of the analysis. The samples were observed with 
an Environmental Scanning Electron Microscope 
(ESEM‑Quanta, FEI Company, The Netherlands), 
which was equipped with an X‑ray microprobe of 
an Energy Dispersive System (EDS, EDAX, USA), in 
order to analyse the chemical composition of any 
possible pollutant present in the kibbles. By using 
the ESEM, it is possible to operate at environmental 
conditions, at normal room pressure, and at low 
vacuum, reducing the possibility of contamination 
and creation of artefacts.
Clinical evaluation 
Dogs received veterinary inspections at the 
beginning of the evaluation and after 15 days. 
A general physical examination (inspection, 
auscultation, percussion, and palpation) was first 
performed to evaluate constitution and skeletal 
development, nutritional status and muscle tonicity, 
Evaluating OTC presence in kibbles
In accordance with relevant literature (Moretti et al. 
2016), we analysed the kibble samples with a UPLC 
Ultimate 3000 Dionex Thermo Fisher system coupled 
to an LCQ‑Orbtrap (Thermo Scientific, San Jose, CA, 
USA) mass spectrometer. High Performance Liquid 
Chromatography (HPLC) analyses were run on a 
Poroshell 120 EC‑C18 column (2.7 μm  _  100 mm, 
3 mm) at 30 °C. The mobile phases were constituted 
with solvent A: water containing 0.1% formic acid (v/v); 
and solvent B: methanol. The gradient programme 
was 0.0 min 5% B, 0.0‑1.0 min 5% B, 1.1‑20.0 min 
95% B, 20.1‑25.0 min 95% B, 25.1‑26.0 min 5% B, 
26.1‑30.00 min 5% B, 11.0‑20.0 min 5% B; running 
at a flow rate of 0.25 mL min‑1. The injection volume 
was set at 5 μL. Analytes were detected with heated 
electrospray ionization (HESI‑II) in positive mode. The 
optimised heated electrospray ionization (HESI‑II) 
temperature was set at 320  °C, and the capillary 
temperature at 300  °C. The electrospray voltage 
was set at 3.00 kV. Sheath and auxiliary gases were 
35 and 15 arbitrary units, respectively. Instrument 
calibration was performed infusing the LTQ Velos 
ESI positive calibration solution. The acquisition was 
achieved in full scan/dd‑MS2. All quantitative data 
were calculated using the full scan data. Mass range 
in full scan was within m/z 150‑1200. The data were 
acquired at a resolution of 70,000 full widths at half 
maximum (FWHM) (m/z 200). The mass spectrometer 
was controlled by Xcalibur 3.0 software (Thermo 
Fisher Scientific, San Jose, CA, USA).
Kibble samples (1 g) were extracted in a polypropylene 
tube, with 8 ml of ethylenediaminetetraacetic acid 
(EDTA) McIlvain buffer pH 4, 1 ml CH3OH, 1 ml CH3CN, 
and 10 ml H2O. The tubes were mechanically mixed 
for 10 minutes, sonicated for 15 minutes, and then 
centrifuged for 10 minutes at 3,500 rpm. Clean up 
was performed on 6 ml SPE cartridge OASIS PRIME 
(Waters) activated with 3  ml CH3OH and 3 ml H2O. 
The supernatant (5 ml) was loaded followed by a 3 ml 
water rinse; OTC was eluted from the cartridge with 
3 ml of CH3OH and then concentrated to dryness in 
a heating block at 45 °C under a stream of nitrogen. 
Dry extract was reconstituted with 14% CH3OH in 
water before the UPLC‑Q‑Orbitrap analysis.
Cell culture
We purchased K562 myelogenous leukemia cell line 
from American Type Culture Collection (ATCC) (LGC 
Standards srl, Milan, Italy). We grew K562 cells in 
RPMI supplemented with 10% fetal bovine serum 
(FBS) 100 μg/mL streptomycin, 100 U/mL penicillin, 
2  mM glutamine (Euroclone Spa, Milan, Italy). The 
cells were cultured in a humidified incubator, which 
provided an atmosphere of 5% CO2 and 95% air at a 
constant temperature of 37 °C. 
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from 32.13 ± 8.72 to 22.13 ± 7.8 mg/dL, respectively 
(*p < 0.05).
Despite the significant variations of metabolic 
parameters these always fell within normal species 
range both at the beginning and after 15 days. 
As to the cytotoxicity assessment of OTC, both in the 
powder and liquid 20% form, results are shown in 
Figure 2.
OTC powder 150 μg/mL (selected on the basis of the 
amount of active principle that is expected to be 
provided to chicken during a treatment according 
to the antibiotic instructions) produced significantly 
cytotoxic results after 24 hours of incubation 
(83% of cell viability, **p < 0.01) and enhanced its 
cytotoxicity at 48 and 72 hours, respectively, with an 
overall cell viability of 67%, ***p < 0.001 (Figure 2C). 
By halving the concentration to 75 μg/mL, a 
significant cytotoxic effect was observed only after 
48 and 72 hours of incubation, with a cell viability of 
82 and 76%, respectively (****p < 0.0001) (Figure 2E). 
A similar trend was observed at a concentration 
of 35 μg/mL, with a cell viability of 79% and 78%, 
respectively (*p < 0.05, ***p < 0.001) (Fig 2G). At a 
concentration of 20 μg/ml, no cytotoxic effect was 
observed (Figure 2I). 
OTC liquid 20% at a concentration of 350  μg/mL 
(chosen on the basis of the amount of antibiotic 
that is expected to be provided to chicken during 
a treatment), resulted in a significantly cytotoxic 
effect at 24, 48, and 72 hours of incubation, with 
a cell viability of 78%, 50%, and 46%, respectively 
(**p < 0.001 and ****p < 0.0001) (Figure 2D). At a 
concentration of 175 μg/mL, a similar trend was 
observed with a cell viability of 87%, 82%, and 66% at 
24, 48, and 72 hours, respectively (*p < 0.05, **p < 0.01 
and ***p  <  0.001) (Figure 2F). A concentration of 
87.5  μg/mL resulted in a significantly cytotoxic 
sensory state, skin and subcutaneous connective 
tissue, the status of lymph nodes, apparent mucous, 
body temperature, arterial pulse, and breath. Then 
a deeper clinical evaluation was also performed. A 
differential diagnosis approach was followed for 
each clinical symptom. In dogs affected by diarrhoea, 
a coprological evaluation was performed to rule out 
the presence of intestinal parasites. In dogs affected 
by otitis, an auricular swab was performed to rule 
out the presence of bacteria, fungi, or mites. In the 
cases of dermatitis, a skin scraper ruled out the 
presence of any mites responsible for demodectic 
or sarcoptic mange; a trichological evaluation ruled 
out the presence of mycetes; and a skin swab ruled 
out the presence of bacteria. None of dogs reported 
any treatment with antibiotics in the last year.
The work detailed here was performed in compliance 
with national Italian and international regulations 
(Italian regulation D.L.vo 116/1992 and European 
Union regulation 86/609/EC) for procedures 
and animal care. We additionally consulted the 
recommendations of the CONSORT 2010 statement 
pertaining to randomised controlled trials (Bian and 
Shang 2011).
Statistical methods
Data were analysed using GraphPad Prism 6 
software (GraphPad Software, Inc., La Jolla, CA, USA). 
All data are presented as the means ± standard error 
of the mean (SEM) and were checked for normality 
test using the D’Agostino‑Pearson normality 
test. Differences in serum OTC concentration and 
biochemical parameters before and after 15 days 
of the new diet supplementation were analysed 
using a Wilcoxon test. A *p < 0.05 was considered 
significant.
Results
An overall significant reduction of otitis, diarrhoea, 
generalised anxiety, and dermatitis after the 
administration of the organic chicken‑based diet.
As shown in Figure 1, a significant decrease in 
mean OTC serum concentration was observed in 
all dogs from an initial value of 0.22 ± 0.12 μg/mL 
to 0.02 ± 0.03 μg/mL after 15 days of the organic 
chicken‑based diet supplementation. 
Biochemical analyses, which are reported in Table I, 
indicate a significant increase in the alkaline 
phosphatase from an initial value of 41  ±  7.74 U/L 
to 52.5 ± 11.84 U/L after 15 days of the organic 
chicken‑based diet supplementation (**p < 0.01). 
Further, we observed a significant decrease in 
Gamma‑glutamyl transferase and urea, from an 
initial value of 9.37 ± 7.61 U/L to 6.25 ± 5.6 U/L and 
Figure 1. Graphical representation of mean oxytetracycline serum 
concentration in dogs before and after 15 days of specific diet 
supplementation. **p < 0.01.
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characterized. This antibiotic is widely used in intensive 
farming to prevent overcrowding and diseases 
associated with promiscuity, as a contaminant of 
meat, bone meal (20‑30%), and poultry by‑products, 
which are some of the main ingredients of pet foods 
(Odore et al. 2015, Di Cerbo et al. 2016b, Mazzeranghi 
et al. 2017, Maine et al. 2015). A high percentage of 
bone meal drags OTC residues that are therefore 
inevitably present in the kibbles of commercially 
available diets, and that can accumulate within a pet’s 
body (Mazzeranghi et al. 2017). It is worth noting that, 
unfortunately, authorities do not investigate possible 
bone contamination, since it is not considered to be 
edible. We previously reported that broiler chickens 
treated with an oral administration of a commercially 
available liquid formulation of OTC 20% had a bone 
and muscle concentration of 1286.3 μg/kg of the 
antibiotic (Odore et  al. 2015). Based on this, a bone 
meal with an OTC concentration of 1286.3  μg/kg 
would drag an approximate rate of 12 μg per 10 gr 
of kibbles. We also observed that after 48 hours 
of incubation with RPMI 1640 growth medium 
diluted 1:2,  1  g of the bone with 1286.3 μg/kg of 
OTC induced a significant apoptosis percentage in 
K562 cells and peripheral blood mononuclear cells 
(PBMCs) (*p < 0.05).
In this study we also demonstrate the usefulness of 
an organic chicken‑based pet food diet made with 
meat that is not derived from intensive farming, 
in relieving otitis, diarrhoea, generalised anxiety, 
and dermatitis in a small cohort of dogs. In fact, we 
observed a significant reduction of the mean OTC 
serum concentration in all dogs after 15 days of 
effect only after 72 hours of incubation, *p  <  0.05 
(Figure 2H), while at a concentration of 40  μg/mL, 
no cytotoxic effect was observed at any time of 
incubation (Figure 2J).
Figure 3 shows a 600X magnification of a kibble 
sample acquired with ESEM. The sample was drawn 
from one of the diets that had been assumed by 
dogs with otitis, diarrhoea, generalised anxiety, and 
dermatitis. The presence of amorphous nanoparticle 
aggregates, mainly constituted by calcium and 
phosphorous (particle A), and calcium, aluminium, 
and silicon (particle B) is clearly visible.
Mass spectrometry analyses produced clear 
evidence of the only presence of OTC residues in 
kibble samples withdrawn from diets provided to 
dogs with otitis, diarrhoea, generalised anxiety, and 
symptoms of dermatitis (Figure 4).
Discussion
Results clearly demonstrate a significant reduction 
of OTC concentration at the end of the evaluation 
period with respect to that at the beginning of the 
evaluation. Biochemical parameters did show some 
significant variation, though these always remained 
within normal ranges. Results relating to cytotoxicity 
demonstrated that both powder and liquid OTC 
showed a significant decrease in cell viability, which 
was time and concentration dependent. Food 
intolerance symptoms regressed with the new 
organic, chicken‑based diet supplementation.
The unavoidable effects of OTC have been well 
Table I. Biochemical parameter changes in dog sera before and after 15 days of specific diet supplementation.
Parameter
Before After 15 days
Mean SD Mean SD
Albumin (g/dL) 2.97 0.09 2.68 0.24
Alkaline phosphatase (U/L) 41.0 7.74 52.5** 11.84
Total bilirubin 0.04 0.1 0.11 0.03
Calcium (mg/dL) 10.0 0.96 9.43 0.49
Cholesterol (mg/dL) 248.5 62.07 253.1 84.75
Creatine phosphokinase (U/L) 244.8 130.3 160.8 75.19
Creatinine (mg/dL) 0.93 0.09 0.98 0.08
Gamma‑glutamyl transferase (U/L) 9.37 7.61 6.25* 5.6
Glucose (mg/dL) 51.75 28.58 66.63 3.66
Glutamic‑oxaloacetic transaminase (U/L) 41.5 5.78 35.88 6.44
Glutamic‑pyruvic transaminase (U/L) 58.0 9.38 53.75 4.62
Phosphorous (mg/dL) 4.92 0.89 4.07 1.15
Total protein (g/dL) 6.67 0.42 6.51 0.34
Triglycerides (mg/dL) 56.38 16.72 66.0 7.84
Urea (mg/dL) 32.13 8.72 22.13* 7.8
*p < 0.05;    ** p < 0.01
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Figure 2. Graphical representation of two different OTC formulation (powder and liquid) cytotoxicity on K562 cell line at 0, 24, 48 and 72 hours of 
incubation. (A) Positive control (K562 cells with RPMI culture medium), (B) negative control (K562 cells with RPMI culture medium and 3% DMSO), (C) 
K562 cells with RPMI culture medium and OTC powder 150 μg/mL, (D) K562 cells with RPMI culture medium and OTC liquid 20% 350 μg/mL, (E) K562 
cells with RPMI culture medium and OTC powder 75 μg/mL, (F) K562 cells with RPMI culture medium and OTC liquid 20% 175 μg/mL, (G) K562 cells 
with RPMI culture medium and OTC powder 35 μg/mL, (H) K562 cells with RPMI culture medium and OTC liquid 20% 87.5 μg/mL, (I) K562 cells with 
RPMI culture medium and OTC powder 15 μg/mL, (J) K562 cells with RPMI culture medium and OTC liquid 20% 40 μg/ml (*p < 0.05; **p < 0.01; 
***p < 0.001 and ****p < 0.0001).
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Figure 4. Chromatograms and tandem Mass spectrometry (MS/MS) spectra of OTC in a1) pet food sample at 19.25 μg/Kg‑1 and in a2) reference 
standard at 1.0 μg/L‑1. 
We have additionally previously reported the 
potential of other diet supplementation in relieving 
clinical symptoms in dogs suffering from chronic 
otitis externa (Di Cerbo et  al. 2016a), chronic 
halitosis (Di Cerbo et al., 2015), Leishmania (Cortese 
et  al. 2015), atopic dermatitis, and gastrointestinal 
disturbs (dehydration, appetite loss, regurgitation, 
the organic chicken‑based diet supplementation. 
This trend is consistent with what Mazzeranghi 
and colleagues report, where 18 cats significantly 
improved their cutaneous adverse food reactions 
symptoms as the OTC serum concentration 
decreased (Mazzeranghi et al. 2017). 
Figure 3. Kibble sample microphotographs (A) along with its Energy Dispersive System spectrum (B) of the two nanoparticle aggregates embedded.
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emesis, abdominal pain, flatulence, borborygma, 
diarrhoea, weight loss, stool consistency, blood, 
and mucus present in the stool) (Di Cerbo et  al. 
2014b), cognitive impairment (Sechi et al. 2015), and 
keratoconjunctivitis sicca (Destefanis et al. 2016).
Findings that indicate the dog serum OTC at only 
0.22 mg/mL – below the cytotoxic concentration 
measured in vitro – is not responsible of the reported 
symptoms. However, the serum concentration did 
not reflect the complete pharmacokinetic of OTC, 
which can accumulate in different organs. Moreover, 
OTC is able to stimulate the immune system even 
at low concentrations as we demonstrated in a 
previous study (Di Cerbo et al. 2016).
We also investigated the presence of OTC in the 
kibbles belonging to the diets provided to dogs that 
developed otitis, diarrhoea, generalised anxiety, and 
dermatitis, therefore ruling out the presence of any 
other antibiotic and tetracycline family member. 
It was possible to observe the only presence of OTC 
at a mean concentration of 19.0 ± 3.7 μg/kg‑1 close to 
the value, which did not result to be cytotoxic in vitro 
(20 μg/mL). This might explain the onset of symptoms 
following the ingestion of contaminated food.
Further microscopic investigation that we carried out 
highlighted the presence of nanoparticle aggregates 
embedded in the kibbles. The EDS spectrum of the 
nanoparticles aggregate A revealed the presence of 
calcium and phosphorous as the main constituents. 
These might be ascribed to the presence of bone 
meal, which have previously been recognised as one 
of the main ingredients of pet food (Di Cerbo et al. 
2016b, Guidetti et al. 2016, Palmieri et al. 2014, Sechi 
et al. 2017, Mazzeranghi et al. 2017, Odore et al. 2015, 
Maine et al. 2015). Intriguingly, EDS spectrum of the 
nanoparticles aggregate B revealed the presence 
of silicon, which is typical of food processing 
procedures that use it as an additive to prevent 
caking in powdered products (Winkler et  al. 2016). 
Although many in vivo studies report the almost 
complete safety of synthetic amorphous silica (SAS), 
none of these studies examine local effects on the 
lymphoid tissue of the gastrointestinal mucosa 
(Rutter and Shott, Winkler et al. 2016). Nanoparticles, 
including those of silica, are known to penetrate the 
gut‑associated lymphoid tissue, impairing tolerance 
towards food constituents (Sass et al. 1990, des Rieux 
et al. 2006, Awaad et al. 2012, Powell et al. 2015) and 
triggering immune‑mediated conditions that carry 
the hallmarks of inflammatory bowel disease (IBD) 
(Zolnik et  al. 2010). Moreover, a recent work from 
Sighinolfi and colleagues demonstrates the inability 
of some nanoparticles to execute neoplastic 
transformation rather their trend to enhance tumour 
progression (Sighinolfi et al. 2016). 
An overall improvement in diarrhoea was observed 
after 48 hours of the organic chicken‑based diet 
supplementation. Conversely, dermatitis and otitis 
took longer periods – from 48 hours to 15 days 
– to completely restore, and were accompanied 
by a consequent reduction of general anxiety, 
which was probably linked to an overall chronic 
inflammatory status (Sechi et al. 2017, Parashar and 
Udayabanu 2016). In light of these observations, it is 
conceivable to hypothesise that a chronic intake of 
contaminated (e.g. OTC) food can induce a chronic 
inflammatory status, enhanced also by the presence 
of nanoparticle aggregates, fostering gut immunity 
and microbiota impairment and consequently 
bringing on symptoms such as otitis, diarrhoea, 
dermatitis, and generalised anxiety (Mayer 2011). 
Our study provides clinical evidence of the presence 
of a plethora of symptoms that may occur in dogs 
fed on commercially available pet food diets where 
OTC is present. Nevertheless, we cannot rule out 
the possible combined pro‑inflammatory activity 
exerted by nanoparticles, whose presence is almost 
unavoidable during the overall production process. 
Given the small cohort of dogs that were considered 
in this study, further research with a larger sample 
size along with well‑detailed immunological 
profiles are needed to support these preliminary 
observations.  
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